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Objectives. This study sought to compare the immediate results
and risk factors for suboptimal outcomes of percutaneous balloon
angioplasty for native versus recurrent aortic obstruction.
Background. Some cardiology centers have been reluctant to
adopt balloon angioplasty for treatment of native aortic coarcta-
tion, while advocating balloon angioplasty over an operation for
treatment of postsurgical or recurrent aortic obstruction.
Methods. Acute results were analyzed from 970 procedures (422
native and 548 recurrent lesions) performed between 1982 and
1995 in 907 patients from 25 centers. An acute suboptimal
outcome was deﬁned as one or more of the following: residual
systolic pressure gradient >20 mm Hg, residual proximal to distal
systolic pressure ratio >1.33 or a major complication (death,
aortic transmural tear, stroke).
Results. Balloon angioplasty signiﬁcantly (p  0.0001) in-
creased lesion diameter for both native (mean [SD] 128  94%)
and recurrent aortic obstruction (97  87%), with a signiﬁcantly
greater increase in the native group (p  0.0001). A reduction in
systolic pressure gradients was signiﬁcant in both groups (p 
0.0001), but slightly higher (p  0.01) for native (74  24%)
versus recurrent obstruction (70  31%). Death associated with
angioplasty was reported in 0.7% of patients with native and in
0.7% of patients with recurrent lesions (p  1.00). An acute
suboptimal outcome was noted with angioplasty in 19% of native
and in 25% of recurrent lesions (p  0.04). Signiﬁcant indepen-
dent risk factors included higher preangioplasty systolic gradient
(odds ratio [OR] 1.39/10-mm Hg increment; 95% conﬁdence
interval [CI] 1.28 to 1.50, p  0.0001), earlier study date (OR
0.92/1-year increment, 95% CI 0.87 to 0.96, p  0.0006), older age
(OR 1.13/5-year increment, 95% CI 1.02 to 1.26, p  0.02) and
recurrent obstruction (OR 1.39 vs. native lesions, 95% CI 1.00 to
1.94, p  0.05).
Conclusions. Acute results and complications of balloon angio-
plasty of native coarctation appear to be equivalent or slightly
superior to those of recurrent aortic obstructions.
(J Am Coll Cardiol 1996;28:1810–7)
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Some cardiology centers have been reluctant to adopt percu-
taneous balloon angioplasty for native aortic coarctation, while
advocating balloon angioplasty over surgical repair for post-
surgical or recurrent aortic obstruction. This was evident in the
early reports from the Valvuloplasty and Angioplasty of Con-
genital Anomalies (VACA) Registry (1,2). Concerns about an
increased risk of acute aortic transmural tear or rupture,
vascular complications in neonates and infants and an in-
creased incidence of late aortic aneurysm formation contrib-
uted to this reluctance to adopt balloon angioplasty for native
aortic coarctation. This viewpoint related to acute results has
been challenged (3). Direct comparisons of acute results of
balloon angioplasty for native coarctation versus recurrent
aortic obstruction have not been made.
We sought to compare the characteristics and acute results
of percutaneous balloon angioplasty for native versus recurrent
aortic obstruction and to determine independent risk factors
for an acute suboptimal result.
Methods
Study group. Immediate results from a total of 1,157
consecutively attempted percutaneous balloon aortic angio-
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plasty procedures performed between April 1982 and Septem-
ber 1995 were submitted from 38 institutions. This includes 341
procedures performed before December 1986, for which the
method of data collection and acute results have been previ-
ously reported (2,4). Data from 11 institutions reporting 87
procedures were excluded, as these institutions had not sub-
mitted data to the Registry since 1990 and were not considered
current. An additional two noncurrent institutions reporting
100 procedures were also excluded, as these institutions had
withdrawn from participation in the Registry. The ﬁnal study
entity therefore consisted of 970 procedures performed in 907
patients from 25 institutions. Procedures were divided into two
groups. The ﬁrst group comprised those procedures in patients
with native thoracic aortic coarctation who had not had
previous procedures, and excludes patients with supravalvar
aortic stenosis or abdominal aortic coarctations. The second
group includes patients with residual, recurrent or surgically
acquired thoracic aortic obstructions either after balloon an-
gioplasty of native obstructions or after surgical coarctation
repair, a Norwood procedure or repair of interrupted aortic
arch, and are hereafter referred to as recurrent aortic obstruc-
tions.
Data collection. Data collected for each procedure in-
cluded the date of procedure and operator, patient selection
characteristics such as age, aortic dimensions, the presence of
associated cardiac lesions and previous procedures and hemo-
dynamic data from cardiac catheterization. Aortic dimensions
were obtained from standard predilation angiography with
correction for magniﬁcation. Technical factors included the
diameter of the balloon(s) and the use of a simultaneous
double balloon technique. This was related to the diameter of
the aorta proximal to the area of stenosis. When a double
balloon technique was used, the effective dilating diameter for
two simultaneous balloons was calculated using the formula
published by Yeager (5). Outcomes assessed included the
immediate postdilation angiographic aortic measurements and
hemodynamic data, as well as complications and mortality.
Data analysis. The distributions of values for predictor and
outcome variables were determined, and frequencies are re-
ported for categoric and ordinal variables and means (SD) or
medians (ranges) for continuous variables, depending on their
distributions. Numbers of patients are given when data are
missing. All analyses were performed using SAS statistical
software (6). Comparisons of angioplasty for native versus
recurrent aortic obstructions were made using the Fisher exact
test, chi-square test, t test and Kruskal-Wallis analysis of
variance. Changes in dimensions and hemodynamic data,
reported as the percent change from baseline, were compared
using paired t tests.
To determine independent factors predictive of acute re-
sults, a suboptimal outcome was arbitrarily deﬁned as the
presence of one or more of the following: residual peak to peak
systolic pressure gradient 20 mm Hg, residual ratio of
proximal to distal peak systolic pressure 1.33 or a major
complication, including death, aortic tear or stroke. Signiﬁcant
predictors from bivariate analyses were further tested using
multiple logistic regression analysis with a forward and back-
ward stepwise variable selection method, with p  0.05 as
criteria for variable selection or removal. Results are reported
as odds ratios (with 95% conﬁdence interval) for a given
increment for continuously measured variables, and relative to
a reference category for categoric variables. Odds ratios of 1
imply no effect on risk, 1 an increased risk and 1 a
decreased risk. Continuously measured variables were further
analyzed by categorizing them and reentering them into the
ﬁnal logistic regression model to determine the nature of the
relation to the outcome.
Results
Patient characteristics. Of the 970 procedures included,
422 were for angioplasty of native aortic coarctation and 548
for recurrent aortic obstruction, with the total number of
procedures reported per institution ranging from 3 to 222
(median 15, mean 39). Of the 25 institutions, ﬁve reported no
angioplasty procedures for native coarctation, and another ﬁve
reported native coarctation angioplasty for 10% of reported
procedures. Institutions with higher volumes reported greater
proportions of procedures for native coarctation.
For those with recurrent coarctation, previous procedures
included resection with end to end anastomosis in 96 (17%),
left subclavian artery ﬂap angioplasty in 79 (14%), synthetic
patch angioplasty in 59 (11%), Norwood procedure in 42 (8%),
extensive aortic arch reconstruction or conduit in 27 (5%),
multiple operations in 10 (2%), previous balloon angioplasty
only in 36 (7%), both previous surgery and balloon angioplasty
in 12 (2%) and an unknown type of native coarctation repair in
187 (34%).
Comparison of native versus recurrent aortic obstruction
balloon angioplasty. Preangioplasty characteristics and early
outcomes. Both groups were similar regarding preangioplasty
characteristics (Table 1), with the exception of an earlier date
of procedure, more complex associated anomalies and a higher
ratio of stenotic lesion to proximal aortic diameter in the
recurrent aortic obstruction group. When comparing out-
comes, signiﬁcant increases in stenotic lesion dimension and
reductions in hemodynamic obstruction were noted in both
groups, but were slightly greater for native coarctation (Table
2). Complications were similar for both groups, with the
exception of more reported intimal tears or ﬂaps in the native
coarctation group, and a greater proportion of those in the
recurrent obstruction group having received blood products.
Mortality. Seven deaths were reported—three patients with
native coarctation and four with recurrent obstructions. Of the
Abbreviations and Acronyms
CI  conﬁdence interval
OR  odds ratio
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three patients with native coarctation, one had Shone’s syn-
drome (age 13 months), one had a complex single ventricle
(9 days) and one had isolated coarctation (age 6 months).
All were critically ill before the procedure and died in the
catheterization laboratory. Autopsy in two of them showed
intimal tears but no aortic rupture, and postdilation angiog-
raphy in the third showed a good result with no aortic
disruption. These deaths were presumed to be related to the
premorbid condition of the patient and not as a direct result
of the procedure.
Of the four patients with recurrent obstruction, one had
isolated recoarctation after patch aortoplasty (age 11 months),
one had complex ventricular inversion and recoarctation after
left subclavian artery ﬂap aortoplasty (age 2.6 years) and two
had recurrent obstruction after stage I Norwood aortic arch
reconstruction (age 2.6 and 4.3 months). One of these latter
patients, who was in critical condition during the procedure,
had a cardiac arrest shortly after dilation; no autopsy was
performed. The other patient who had a Norwood procedure
underwent successful dilation but died 1 h later of retroperi-
toneal bleeding due to a tear in the iliac artery; autopsy showed
that the aortic dilation site was intact. The patient with
complex ventricular inversion was stable after the procedure
but died unexpectedly 14 h later; autopsy showed the aortic
dilation site was intact with good relief of obstruction. The ﬁnal
patient with isolated coarctation had an uneventful dilation but
developed neurologic signs after the procedure. Investigations
revealed hemorrhagic cerebral infarcts, and the patient devel-
oped acute cerebral edema with herniation and brain death.
Autopsy revealed an incomplete circle of Willis, and the
cerebral event was thought to be due to occlusion of the left
carotid artery by the dilating catheter during the dilation.
Risk factors for a suboptimal outcome. A suboptimal
outcome, as previously deﬁned, was noted for 80 procedures
(19%) for native coarctation and 135 procedures (25%) for
recurrent obstruction (p  0.04). If we arbitrarily deﬁne a
difference of at least 5% as clinically signiﬁcant, we have a
power of 0.60 at alpha 0.05 to detect this difference. Our
observed difference was greater than this, although marginally
so, and we therefore are conﬁdent in concluding that the
reported superiority of dilation of recurrent obstructions over
native coarctation is not valid. In bivariate analysis, signiﬁ-
cantly more suboptimal outcomes occurred earlier in the
experience (p  0.0001). Patients with a suboptimal outcome
were signiﬁcantly older (median age 4.1 vs. 3.5 years; p 0.04).
There were no signiﬁcant differences regarding associated
cardiac anomalies. There was no effect of ratio of balloon to
proximal aortic diameter on suboptimal outcome, with a mean
ratio of 1.09  0.29 (n  129) for patients with a suboptimal
outcome versus 1.09  0.21 (n  448) for those without a
suboptimal outcome (p  0.83). This ratio also had no
signiﬁcant effect on any outcome variable for either native or
recurrent obstruction. Before angioplasty, patients with a
suboptimal outcome had similar ratios of proximal to stenotic
lesion diameter, but signiﬁcantly higher systolic gradients
(53  22 [n  211] vs. 39  19 mm Hg [n  744], p  0.0001)
and higher ratios of proximal to distal systolic pressure (1.67
0.42 [n  209] vs. 1.47  0.28 [n  740], p  0.0001). Patients
with suboptimal outcomes had lesser percent increases in the
stenotic lesion diameter (91  86% [n  124] vs. 115  92%
[n  478], p  0.008) and lesser percent increases in the ratio
of stenotic lesion to proximal aortic diameter (85  85% [n 
62] vs. 111  92% [n  252], p  0.04).
Independent risk factors. Signiﬁcant independent risk fac-
tors for early suboptimal outcome included a higher pre-
angioplasty systolic gradient, earlier procedure date, older
patient age and recurrent obstruction (Table 3). When
procedures from institutions that had not reported any
dilation procedures for native aortic obstructions were
excluded (n  44), age and recurrent obstruction no longer
entered signiﬁcantly into the multiple logistic models, with
no change in the odds ratios for preangioplasty gradient or
date of procedure.
Preangioplasty systolic gradient and patient age. The indepen-
dent effect of preangioplasty systolic gradient was further ex-
plored by categorizing this variable and reentering it into the ﬁnal
regression model. The independent effect of systolic gradient
appears to be linear (Fig. 1). Patient age was likewise analyzed









Mean study interval (yr)* 7.9  3.1 7.4  3.1 0.02
Patient age (n  419) (n  540)
Median 4.2 yr 2.7 yr 0.98
Range 2 days–63 yr 15 days–54 yr
Associated cardiac anomalies
Aortic valve stenosis 30 (7%) 26 (5%) 0.12
Subaortic stenosis 13 (3%) 19 (4%) 0.74
Bicuspid aortic valve 44 (10%) 44 (8%) 0.20
Mitral valve stenosis 12 (3%) 12 (2%) 0.52
Ventricular septal defect 39 (9%) 55 (10%) 0.68
Complex anomalies 13 (3%) 84 (15%) 0.0001
Use of simultaneous double-balloon
technique
16 (4%) 26 (5%) 0.47
Mean ratio of balloon to proximal 1.07 0.21 1.10  0.25 0.07
aortic diameter (n  266) (n  311)
Mean aortic diameter (mm)
Proximal 10.5  4.6 10.2  4.2 0.38
(n  266) (n  383)
Stenotic lesion 4.4  2.8 5.0  2.9 0.01
(n  298) (n  419)
Distal 12.8  5.5 12.0  5.1 0.06
(n  225) (n  360)
Mean ratio of stenotic lesion to 0.41 0.15 0.48  0.20 0.0001
proximal aortic diameter (n 232) (n  360)
Mean systolic gradient (mm Hg) 42 18 41  22 0.44
(n  413) (n  542)
Mean ratio of proximal to distal 1.52 0.26 1.51  0.37 0.80
systolic pressure (n  411) (n  538)
*Interval from ﬁrst reported procedure to VACA Registry. Data presented
are mean value  SD or number (%) of patients, unless otherwise indicated.
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and showed an overall trend of increasing risk with increasing age,
with a slightly increased risk in neonates (Fig. 2).
Type of aortic obstruction. The independent effect of spe-
ciﬁc aortic obstruction subtypes was also explored (Fig. 3).
With native coarctation set as the reference group, patients
who had coarctation repair with resection with end to end
anastomosis (p  0.04) or synthetic patch angioplasty (p 
0.03) had a signiﬁcantly higher adjusted risk of acute subopti-
mal outcome than patients with native coarctation. Increased
but not signiﬁcant risk was noted for patients who had aortic
arch reconstruction, multiple operations or a combination of
surgical repair and balloon angioplasty.
Figure 1. Independent effect of preangioplasty systolic pressure gra-
dient on risk of a suboptimal outcome. Odds ratios with 95% conﬁ-
dence intervals (CI) adjusted for procedure date, patient age and
recurrent obstruction from multiple logistic regression are plotted
against preangioplasty systolic gradient.









Mean change in aortic diameter
Proximal 2  11% 2  15% 0.75
(n  102, p  0.07) (n  223, p  0.13)
Stenotic lesion 128  94% 97  87% 0.0001
(n  259, p  0.0001) (n  343, p  0.0001)
Distal 3  15% 1  7% 0.23
(n  91, p  0.04) (n  123, p  0.02)
Mean ratio of stenotic lesion to proximal aortic 0.84 0.18 0.83  0.22 0.78
diameter after angioplasty (n  98) (n  205)
Mean change in ratio of stenotic lesion to proximal 125  90% 98  90% 0.01
aortic diameter (n  96, p  0.0001) (n  218, p  0.0001)
Median systolic gradient after angioplasty (mm Hg) 9 (0–65) 9 (0–82) 0.44
(n  412) (n  509)
Mean ratio of proximal to distal systolic pressure 1.11 0.10 1.13  0.15 0.05
after angioplasty (n  404) (n  477)
Mean change in hemodynamic variables 74  24% 70  31% 0.01
Systolic gradient (n  405, p  0.0001) (n  530, p  0.0001)
Ratio of proximal to distal systolic pressure 26  11% 23  14% 0.005
(n  399, p  0.0001) (n  498, p  0.0001)
Complications
Any complication 63 (15%) 72 (13%) 0.41
Death 3 (0.7%) 4 (0.7%) 1.00
Transmural aortic tear 0 4 (0.7%) 0.14
Neurologic event 3 (0.7%) 3 (0.6%) 1.00
Reported intimal tear/ﬂap 22 (5.2%) 9 (1.6%) 0.002
Vascular
Pulse loss 19 (4.5%) 10 (3.7%) 0.50
Thrombolysis required 1 (0.2%) 3 (0.6%) 0.64
Operation required 2 (0.5%) 7 (1.3%) 0.31
Blood products given 13 (4.1%) 52 (15%) 0.0001
Data presented are mean value  SD, median (range) or number (%) of patients.
Table 3. Independent Risk Factors for a Suboptimal Outcome*
Characteristic OR (95% CI)
p
Value
Preangioplasty systolic gradient (per
10-mm Hg increment)
1.39 (1.28–1.50) 0.0001
Study interval (per 1-year increment) 0.92 (0.87–0.96) 0.0006
Patient age (per 5-year increment) 1.13 (1.02–1.26) 0.02
Recurrent obstruction (vs. native
coarctation)
1.39 (1.00–1.94) 0.05
*From multiple logistic regression analysis (n  944); suboptimal outcome
was deﬁned as one or more of the following: residual systolic pressure gradient
20 mm Hg, residual proximal to distal systolic pressure ratio 1.33 or major
complication deﬁned as death, transmural aortic tear or stroke. CI  conﬁdence
interval; OR  odds ratio.
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Institutional experience. The signiﬁcant effect of date of
procedure was also explored to determine the effect of evolving
experience on acute results. Variables reﬂective of experience
were created and included number of procedures (number of
procedures reported by a given institution), time of adoption of
procedure (time from ﬁrst ever reported procedure to the
Registry to the ﬁrst procedure reported by each institution),
length of experience (time from an institution’s ﬁrst to the
most recent procedure reported from a given institution),
intensity of experience (total number of procedures divided by
the length of experience for a given institution), time of
procedure (time from ﬁrst ever procedure reported from an
institution to each subsequent procedure from a given institu-
tion, and time from the ﬁrst ever procedure reported to the
Registry to each procedure reported). When these variables
were tested with stepwise selection in a multiple logistic
regression model including pre-angioplasty gradient, age and
recurrent versus native obstruction, only an institution’s total
number of procedures and the time of each case in the whole
Registry’s experience were signiﬁcant. Exploration by catego-
rization of the variable institution’s total number of pro-
cedures showed that the increased risk was greatest for proce-
dures performed at institutions that had reported 50 proce-
dures. Odds of a suboptimal outcome relative to procedures
reported from institutions reporting 100 procedures (odds
ratio [OR] set at 1.00) were as follows for each institutional
reporting category: 10 or fewer procedures, OR 1.96; 11 to 20
procedures, OR 1.94; 21 to 50 procedures, OR 2.74; 51 to 100
procedures, OR 1.09. This was unrelated to the time over
which the number of procedures had been performed. Like-
wise, the variable time of each case in the Registry’s experience
was categorized and reentered into the multiple logistic model.
Relative to the most current 5 years, increased odds of an acute
suboptimal outcome was greatest for the ﬁrst 2 years (OR 6.26)
and decreased over the intervening 6 years (OR 1.69) of the
Registry’s reported experience. These institutional experience
effects are signiﬁcant after controlling for differences relating
to pre-angioplasty gradient, age and recurrent obstruction.
Suboptimal relief of obstruction. A similar analysis was
performed to determine independent risk factors for subopti-
mal relief of obstruction only, deﬁned as an immediate residual
systolic gradient 20 mm Hg or a proximal to distal pressure
ratio 1.33, regardless of complications. This outcome was
noted for 18% of procedures for native coarctation versus 26%
of procedures for recurrent aortic obstruction (p  0.02). In
logistic regression analysis the same risk factors as for an acute
suboptimal outcome were signiﬁcant for suboptimal relief of
Figure 2. Independent effect of patient age on risk of a suboptimal
outcome. Odds ratios with 95% conﬁdence intervals adjusted for
preangioplasty systolic pressure gradient, procedure date and recoarc-
tation from multiple logistic regression are plotted against patient age.
m  month or months; y  years.
Figure 3. Independent effect of speciﬁc previous procedures
on risk of a suboptimal outcome. Odds ratios with 95%
conﬁdence intervals (CI) adjusted for preangioplasty systolic
pressure gradient, procedure date and patient age from multi-
ple logistic regression are plotted against speciﬁc previous
procedures. Ball  balloon angioplasty; both  both previous
surgical repair and balloon angioplasty; E to E resection with
end to end anastomosis; LSA ﬂap  left subclavian artery ﬂap
angioplasty; NCoA  native coarctation; mult surg  multiple
previous surgical repairs; Norw  Norwood procedure;
patch  synthetic patch angioplasty; recon  aortic arch
reconstruction; unkn surg  unknown type of surgical repair.
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obstruction, with similar odds ratios as follows: preangioplasty
systolic gradient, 1.42/10-mm Hg increment (p 0.0001); study
time interval, 0.93/1-year increment (p  0.004); patient age,
1.15/5-year increment (p  0.01); and recurrent obstruction,
1.43 versus native coarctation (p  0.04). Balloon to proximal
aortic diameter ratios were not signiﬁcantly related to relief of
obstruction.
Discussion
Our analysis of 970 percutaneous balloon aortic angioplasty
procedures showed early relief of obstruction without major
complications for 81% of procedures for native coarctation
and 75% of procedures for recurrent aortic obstruction. Major
complications (death, transmural aortic tear, stroke) were
noted for only 1.6% of procedures.
Study limitations. This study represents the largest series
of patients undergoing percutaneous balloon angioplasty of
aortic obstruction. The results must, however, be viewed in
light of the limitations of this study. The recurrent obstruction
group is very heterogeneous regarding the type of previous
procedures that had been performed. However, the large
patient numbers in this study permitted subgroup analysis in
multiple logistic regression analysis, with adjustments made for
other signiﬁcant predictors of outcome. No attempt was made
to standardize patient selection or procedural techniques
between or within institutions. Readers interested in learning
more about recommended techniques and controversies sur-
rounding technical details of these procedures are referred to
textbooks by Lock et al. (7) and Rao (8). Information related
to other potentially important predictors and outcomes was
not collected. The site of measurement of proximal and distal
aortic diameters was not standardized. Measurements col-
lected did not allow consideration of whether associated
proximal aortic arch hypoplasia was present, and these patients
were not excluded. Similar but signiﬁcant amounts of measure-
ment data are missing, and the results of analysis of changes in
aortic dimensions and the effect of the ratio of balloon to
proximal aortic diameter must be viewed with particular
caution. Systematic reporting bias cannot be ruled out.
Risk factors for an early suboptimal outcome. Risk factors
were carefully evaluated and included a higher preangioplasty
systolic pressure gradient, earlier procedure date, older patient
age and presence of recurrent obstruction. Beekman et al. (4)
also observed a relation between higher pre-angioplasty gradi-
ent and suboptimal outcomes. Rao and Koscik (9) identiﬁed a
smaller isthmus to proximal aortic dimension before angio-
plasty as a signiﬁcant risk factor for recurrence after dilation of
native coarctation.
Unlike with balloon dilation of valvar obstructions, the
degree of immediate gradient reduction was not signiﬁcantly
related to balloon sizing. This may reﬂect the heterogeneity of
anatomic mechanisms of aortic obstruction, variations or er-
rors in measurements and the effect of associated transverse
aortic arch hypoplasia. Tyagi et al. (10) showed poor results
with dilation of long segment tubular versus discrete native
coarctations. Anjos et al. (11) showed an effect of increased
ratio of balloon to distal aortic diameter on improved results at
follow-up after dilation of recurrent coarctation. A preliminary
study of the adjunctive use of balloon-expandable stents has
shown further improvement in early results (12).
Institutional factors were associated with outcome. More
recent improved results may be related to increasing operator
skill and experience and to improvements in balloon and
catheter technology. The institutions reporting the largest
procedural volumes might also be expected to have operators
with the greatest experience. In a similar analysis of percuta-
neous balloon aortic valvotomy, an individual operator’s suc-
cessive experience was most predictive of improving results
(13).
Increasing patient age predicted poor results, and was
suggested by Hellenbrand et al. (1) in an earlier report from
the VACA Registry. Long-standing aortic obstruction may be
associated with increased ﬁbrotic change in the aorta and
might suggest a plan of earlier rather than later intervention by
balloon angioplasty techniques. However, this ﬁnding may not
reﬂect follow-up results, and some series have shown an
increased risk of recurrence in younger patients (9,14,15).
Risk of an early suboptimal outcome was greater with
recurrent aortic obstructions and was related to the speciﬁc
type of previous procedure(s). This may reﬂect differing de-
grees of distensibility secondary to increased scar formation
associated with certain types of surgical repairs.
Although early results may be slightly better for native
coarctation, data regarding long-term outcome may be of
greater interest. Encouraging medium-term follow-up results
of balloon angioplasty of native coarctations have been re-
ported and suggest that beyond infancy obstruction relief is
maintained (14,15). Native coarctation dilations in neonates
and infants remain controversial, and despite good early
results a signiﬁcant recurrence risk is reported (9,14–17). We
show that repeat balloon angioplasty is successful for recurrent
obstruction after initial balloon angioplasty.
Balloon angioplasty of native versus recurrent aortic ob-
struction. Over the period of this multicenter experience a
shift in practice occurred, with more dilations of native coarc-
tation being reported later, implying an initial reluctance to
adopt balloon angioplasty of native coarctations (3). Several
factors may be implicated. There was a bias that dilation of
recurrent obstructions was safer because of the supporting
surgical scar tissue, with a reduced risk of acute aortic rupture.
We have shown that transmural aortic tears have not been seen
with dilation of native coarctations, and are rare with dilation
of recurrent obstructions. Aneurysm formation at dilation sites
remains a long-term concern. Preexisting cystic medial necrosis
commonly noted on histologic examination of aortas with
untreated native coarctation may predispose to aneurysm
formation (18). In early reports, Brandt et al. (19) and Cooper
et al. (20) noted a signiﬁcant incidence of aneurysm formation
during short-term follow-up. More recent single-institution
series have reported a much lower incidence of aneurysm
formation both in short-term and long-term follow-up
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(14,15,21–24). The importance of avoiding overdistention of
the coarctation segment by careful balloon size selection is now
better understood, and guide wire and catheter manipulation
across a freshly dilated coarctation segment is known to
increase the risk of aortic tear or perforation (25). The
recognition that late aneurysm formation can occur after
surgical repair, regardless of the type of repair, may also have
contributed to the increased interest in balloon angioplasty
treatment for native coarctation (26,27).
Other complications, including the risk of death, were
similar in both groups. Causes of death were often related to
the condition of the patient before the procedure and not
directly to the procedure. Complications related to femoral
artery injury were also similar in both groups, but under-
reporting may have occurred. The incidence, although compa-
rable to earlier reports from the VACA Registry (1,3), may be
higher at follow-up and related to the age at angioplasty
(15,28).
Conclusions. Balloon angioplasty of native coarctation and
recurrent aortic obstruction in children has become a widely
applied treatment, as demonstrated in this large multicenter
experience. The risk of acute procedural complications is low
and obstruction is relieved in the majority of patients. Acute
results appear to be equivalent with both native and recurrent
obstructions. Comparisons with surgical results are fraught
with bias (29). Coarctation of the aorta is a heterogeneous
disorder occurring with varying degrees of arch hypoplasia and
associated intracardiac defects. By comparing unselected series
of surgical and balloon angioplasty series, the two groups are
rarely equal and may differ in subtle ways that could have a
signiﬁcant impact on outcomes. Although studies of medium-
term follow-up of angioplasty procedures are encouraging, the
long-term fate of these dilated aortas must await long-term
follow-up studies of large series of patients.
Appendix
Participating VACA Registry Investigators
C. Mullins, Texas Children’s Hospital, Houston, Texas; L. Benson and B.
McCrindle, The Hospital for Sick Children, Toronto, Ontario, Canada; R.
Beekman and T. Lloyd, University of Michigan, Ann Arbor, Michigan; T. Jones,
Children’s Hospital and Medical Center, Seattle, Washington; V. Fontes,
Instituto “Dante Pazzanese” de Cardiologia, Sao Paolo, Brazil; J. Murphy and J.
Rome, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; J.
Cheatham and C. Foreman, University of Nebraska Medical Center, Omaha,
Nebraska; J. Finley, I.W. Killam Hospital for Children, Halifax, Nova Scotia,
Canada; S. Nouri and P.S. Rao, Cardinal Glennon Children’s Hospital, St. Louis,
Missouri; R. Collins-Nakai, University of Alberta, Edmonton, Alberta, Canada;
D. Girod and S. Parikh, Riley Hospital for Children, Indianapolis, Indiana; L.
Latson, Cleveland Clinic, Cleveland, Ohio; A. Rocchini, University of Minnesota
Hospital, Minneapolis, Minnesota; R. Morrow, Children’s Hospital of Michigan,
Detroit, Michigan; E. Colvin, University of Alabama at Birmingham Hospital,
Birmingham, Alabama; H. Allen, Children’s Hospital of Columbus, Columbus,
Ohio; R. Cooper, North Shore University Hospital, Manhasset, New York; D.
Hagler, The Mayo Clinic, Rochester, Minnesota; D. Fischer, Children’s Hospital
of Pittsburgh, Pittsburgh, Pennsylvania; T. Akagi, Kurume University, Kurume,
Japan; V. Zales, Children’s Memorial Hospital, Chicago, Illinois; G. Ben
Shachar, Rainbow Babies and Childrens Hospital, Cleveland, Ohio; S. Shapiro,
Georgetown University Hospital, Washington, DC.
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